148 related articles for article (PubMed ID: 37202600)
1. Association of chronic statin use, myopenia, myosteatosis and major morbidity in surgical patients with upper gastrointestinal cancer.
Cereda M; Bernasconi DP; Uggeri F; Ippolito D; Di Lucca G; Maino C; Gandola D; Braga M; Sandini M; Gianotti L
Updates Surg; 2023 Dec; 75(8):2297-2303. PubMed ID: 37202600
[TBL] [Abstract][Full Text] [Related]
2. Assessment of muscle mass using chest computed tomography-based quantitative and qualitative measurements in patients with systemic sclerosis: A retrospective study with cross-sectional and longitudinal analyses.
da Rocha DS; Tessari JA; Mainardi NB; Hax V; Gasparin AA; de Oliveira CAV; Garcia TS; Xavier RM; Chakr RMDS
Semin Arthritis Rheum; 2023 Apr; 59():152168. PubMed ID: 36736023
[TBL] [Abstract][Full Text] [Related]
3. Clinical Impact of Muscle Quantity and Quality in Colorectal Cancer Patients: A Propensity Score Matching Analysis.
Okugawa Y; Toiyama Y; Yamamoto A; Shigemori T; Yin C; Narumi A; Omura Y; Ide S; Kitajima T; Fujikawa H; Yasuda H; Hiro J; Yoshiyama S; Kobayashi M; Araki T; McMillan DC; Miki C; Kusunoki M
JPEN J Parenter Enteral Nutr; 2018 Nov; 42(8):1322-1333. PubMed ID: 29761898
[TBL] [Abstract][Full Text] [Related]
4. Impact of Low Muscularity and Myosteatosis on Long-term Outcome After Curative Colorectal Cancer Surgery: A Propensity Score-Matched Analysis.
Sueda T; Takahasi H; Nishimura J; Hata T; Matsuda C; Mizushima T; Doki Y; Mori M
Dis Colon Rectum; 2018 Mar; 61(3):364-374. PubMed ID: 29377869
[TBL] [Abstract][Full Text] [Related]
5. Impact of myopenia and myosteatosis on postoperative outcome and recurrence in Crohn's disease.
Pozios I; Kaufmann D; Boubaris K; Seeliger H; Weixler B; Stroux A; Kamphues C; Margonis GA; Kreis ME; Beyer K; Seifarth C; Lauscher JC
Int J Colorectal Dis; 2022 Apr; 37(4):791-804. PubMed ID: 35156133
[TBL] [Abstract][Full Text] [Related]
6. AI-based CT Body Composition Identifies Myosteatosis as Key Mortality Predictor in Asymptomatic Adults.
Nachit M; Horsmans Y; Summers RM; Leclercq IA; Pickhardt PJ
Radiology; 2023 Jun; 307(5):e222008. PubMed ID: 37191484
[TBL] [Abstract][Full Text] [Related]
7. Impact of myopenia and myosteatosis in patients undergoing abdominal surgery for chronic pancreatitis.
O'Brien SJ; Bhutiani N; Young JI; Phillips P; Weaver KH; Kline D; Vitale GC
Surgery; 2022 Jul; 172(1):310-318. PubMed ID: 35246331
[TBL] [Abstract][Full Text] [Related]
8. Influence of body composition profile on outcomes following colorectal cancer surgery.
Malietzis G; Currie AC; Athanasiou T; Johns N; Anyamene N; Glynne-Jones R; Kennedy RH; Fearon KC; Jenkins JT
Br J Surg; 2016 Apr; 103(5):572-80. PubMed ID: 26994716
[TBL] [Abstract][Full Text] [Related]
9. Close Relationship Between Immunological/Inflammatory Markers and Myopenia and Myosteatosis in Patients With Colorectal Cancer: A Propensity Score Matching Analysis.
Okugawa Y; Toiyama Y; Yamamoto A; Shigemori T; Kitamura A; Ichikawa T; Ide S; Kitajima T; Fujikawa H; Yasuda H; Okita Y; Hiro J; Araki T; McMillan DC; Miki C; Kusunoki M
JPEN J Parenter Enteral Nutr; 2019 May; 43(4):508-515. PubMed ID: 30334265
[TBL] [Abstract][Full Text] [Related]
10. Influence of nutritional status and body composition on postoperative events and outcome in patients treated for primary localized retroperitoneal sarcoma.
Ramanovic M; Novak M; Perhavec A; Jordan T; Popuri K; Kozjek NR
Radiol Oncol; 2024 Mar; 58(1):110-123. PubMed ID: 38378038
[TBL] [Abstract][Full Text] [Related]
11. Assessment of Computed Tomography (CT)-Defined Muscle and Adipose Tissue Features in Relation to Short-Term Outcomes After Elective Surgery for Colorectal Cancer: A Multicenter Approach.
Martin L; Hopkins J; Malietzis G; Jenkins JT; Sawyer MB; Brisebois R; MacLean A; Nelson G; Gramlich L; Baracos VE
Ann Surg Oncol; 2018 Sep; 25(9):2669-2680. PubMed ID: 30006691
[TBL] [Abstract][Full Text] [Related]
12. The impact of sarcopenia and myosteatosis on postoperative outcomes and 5-year survival in curatively operated colorectal cancer patients - A retrospective register study.
Aro R; Mäkäräinen-Uhlbäck E; Ämmälä N; Rautio T; Ohtonen P; Saarnio J; Meriläinen S
Eur J Surg Oncol; 2020 Sep; 46(9):1656-1662. PubMed ID: 32224072
[TBL] [Abstract][Full Text] [Related]
13. Low Muscularity and Myosteatosis Is Related to the Host Systemic Inflammatory Response in Patients Undergoing Surgery for Colorectal Cancer.
Malietzis G; Johns N; Al-Hassi HO; Knight SC; Kennedy RH; Fearon KC; Aziz O; Jenkins JT
Ann Surg; 2016 Feb; 263(2):320-5. PubMed ID: 25643288
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of myosteatosis and sarcopenia for elderly patients with colorectal cancer: A large-scale double-center study.
Chen WZ; Shen ZL; Zhang FM; Zhang XZ; Chen WH; Yan XL; Zhuang CL; Chen XL; Yu Z
Surgery; 2022 Oct; 172(4):1185-1193. PubMed ID: 35868905
[TBL] [Abstract][Full Text] [Related]
15. Psoriasis Is Associated With Myosteatosis but Not Sarcopenia: A Case-Control Study.
Chen X; Xiang H; Tan L; Zhou J; Tang J; Hu X; Yang M
Front Med (Lausanne); 2021; 8():754932. PubMed ID: 34722590
[No Abstract] [Full Text] [Related]
16. Obesity, Sarcopenia and Myosteatosis: Impact on Clinical Outcomes in the Operative Management of Crohn's Disease.
Donnelly M; Driever D; Ryan ÉJ; Elliott JA; Finnegan J; McNamara D; Murphy I; Conlon KC; Neary PC; Kavanagh DO; O'Riordan JM
Inflamm Bowel Dis; 2023 Oct; ():. PubMed ID: 37861366
[TBL] [Abstract][Full Text] [Related]
17. Abdominal CT metrics in 17,646 patients reveal associations between myopenia, myosteatosis, and medical phenotypes: a phenome-wide association study.
Zambrano Chaves JM; Lenchik L; Gallegos IO; Blankemeier L; Liang T; Rubin DL; Willis MH; Chaudhari AS; Boutin RD
EBioMedicine; 2024 May; 103():105116. PubMed ID: 38636199
[TBL] [Abstract][Full Text] [Related]
18. Nutritional status and skeletal muscle status in patients with head and neck cancer: Impact on outcomes.
Findlay M; White K; Brown C; Bauer JD
J Cachexia Sarcopenia Muscle; 2021 Dec; 12(6):2187-2198. PubMed ID: 34676673
[TBL] [Abstract][Full Text] [Related]
19. Laparoscopic colorectal cancer surgery combined with enhanced recovery after surgery protocol (ERAS) reduces the negative impact of sarcopenia on short-term outcomes.
Pędziwiatr M; Pisarska M; Major P; Grochowska A; Matłok M; Przęczek K; Stefura T; Budzyński A; Kłęk S
Eur J Surg Oncol; 2016 Jun; 42(6):779-87. PubMed ID: 27156809
[TBL] [Abstract][Full Text] [Related]
20. The impact of sarcopenia and myosteatosis on outcomes of unresectable pancreatic cancer or distal cholangiocarcinoma.
Rollins KE; Tewari N; Ackner A; Awwad A; Madhusudan S; Macdonald IA; Fearon KC; Lobo DN
Clin Nutr; 2016 Oct; 35(5):1103-9. PubMed ID: 26411749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
